Saturday, July 11, 2026

pharma · NSCLC

Zibo Municipal Hospital

Zibo Municipal Hospital is a pharma organization headquartered in CN. Primary therapeutic focus areas include NSCLC. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity fr

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
1
Patents
0
Clinical program

SBRT combined with Tislelizumab followed by Tislelizumab

Phase 2 · small molecule · NSCLC

SBRT combined with Tislelizumab followed by Tislelizumab for NSCLC is a Phase 2 program (small_molecule) at Zibo Municipal Hospital with 1 ClinicalTrials.gov record(s).

← All Zibo Municipal Hospital projects Phase 2 small molecule active

Internal code 2024-Ethical Review -01

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Zibo Municipal Hospital
Phase
Phase 2
Modality
small_molecule
Indication
NSCLC
Status
active
Trials
1